RNA's logo.
Ticker Symbol: RNA

Avidity Biosciences Inc

$26.67 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001599901

Company Profile

Avidity Biosciences, Inc. is driven to change lives with a new class of therapies called Antibody Oligonucleotide Conjugates (AOCs) that are designed to overcome current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Avidity's proprietary AOC platform combines the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. Avidity's lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, and its other muscle programs are focused on the treatment of Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, Pompe disease and muscle atrophy. In addition to its muscle franchise, Avidity has research efforts focused on immune, cardiac and other cell types.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 10578 Science Center Drive
CEO: Sarah Boyce
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $6.18
Change: $0.07 ( 1.15%)
Days Range: $5.92 - $6.31
Beta: 0.64
52wk. High: $25.74
52wk. Low: $5.35
Ytd. Change -71.00%
50 Day Moving Average: $6.50
200 Day Moving Average: $10.01
Shares Outstanding: 74096207

Valuation

Market Cap: 45.8B
PE Ratio: -2.01
EPS (TTM): -3.07

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A